SEC Form 4 · accession 0001127602-16-057030
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Massaro
Director
Period of report
Jul 1, 2016
Accepted (ET)
Jul 5, 2016 · 1:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2016 | S | 100 | $83.41 | D | 15,095 | D | |
| Common Stock | Jul 1, 2016 | S | 100 | $83.45 | D | 14,995 | D | |
| Common Stock | Jul 1, 2016 | S | 100 | $83.47 | D | 14,895 | D | |
| Common Stock | Jul 1, 2016 | S | 100 | $83.51 | D | 14,795 | D | |
| Common Stock | Jul 1, 2016 | S | 100 | $83.56 | D | 14,695 | D | |
| Common Stock | Jul 1, 2016 | S | 100 | $83.58 | D | 14,595 | D | |
| Common Stock | Jul 1, 2016 | S | 100 | $83.66 | D | 14,495 | D | |
| Common Stock | Jul 1, 2016 | S | 100 | $83.67 | D | 14,395 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.